Our findings are supported by a previous study demonstrating that AGOM treatment decreased the release of cytokines (TNF-α, IL-6 and IL-1β) and restored BDNF levels and the activity of the antioxidant enzymes CAT and GPx in the brain in an HFD-induced anxiety-like behavior model [23]. The gene discussed is CAT; the disease is Anxiety.